BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 13, 2010
View Archived Issues
Clinical data show improved antihypertensive efficacy of intensive amlodipine/valsartan/HCTZ
Read More
Novel stearoyl-CoA desaturase inhibitors disclosed by Gilead
Read More
GlaxoSmithKline claims novel antibacterial agents
Read More
Novel PKB alpha/Akt1 inhibitors discovered at GlaxoSmithKline
Read More
DNA Medicine Institute receives grant for noninvasive malaria test
Read More
Galapagos and Roche expand COPD therapy alliance
Read More
Harbor Biosciences reports results of phase IIa Triolex trial in diabetes
Read More
Envivo initiates phase IIb EVP-6124 trial in Alzheimer's disease
Read More
Quest PharmaTech doses first patient in prostate cancer trial
Read More
MAP Pharmaceuticals provides update on Levadex development program
Read More
Promising preclinical effect of pan PI3Kalpha inhibitor NVP-BKM-120 disclosed
Read More
Eotaxin serum levels, retinal expression increased in age-related macular degeneration
Read More
FLT3/ITD kinase inhibitors ITRI-260 and ITRI-376 potential candidates for AML treatment
Read More
Seasonal flu vaccine VAX-125 immunogenic in elderly subjects
Read More
BioChromix discovers novel thiophene derivatives
Read More
Phase III data on AIDSVAX gp120 B/E and ALVAC vCP1521 show protective effect
Read More
IntelGenx acquires full ownership of CPI-300 from Cary
Read More
Lundbeck discovers novel tachykinin NK3 antagonists
Read More
GSK and Response Genetics enter license agreement for BRAF gene mutation testing
Read More
FDA advisory committee review of Luveniq NDA set for June
Read More
Abbott licenses Zydus Cadila products for fast-growing emerging markets
Read More
First quarter developments at Merck & Co.
Read More
Eisai receives Japanese approval of Tambocor for tachyarrhythmia in children
Read More
Schering-Plough launches Temodal injection in Japan
Read More
GSK and FDA report important safety finding from Promacta study in chronic liver disease
Read More
Cell Therapeutics and NCCTG to conduct phase II study of pixantrone in metastatic breast cancer
Read More